Dual Antiplatelet Therapy Discontinuation, Platelet Reactivity, and Adverse Outcomes After Successful Percutaneous Coronary Intervention

Redfors, B., Kirtane, A. J., Liu, M., Musikantow, D. R., Witzenbichler, B., Rinaldi, M. J., Metzger, D. C., Weisz, G., Stuckey, T. D., Brodie, B. R., Ben-Yehuda, O., Mehran, R., & Stone, G. W. (2022). Dual Antiplatelet Therapy Discontinuation, Platelet Reactivity, and Adverse Outcomes After Successful Percutaneous Coronary Intervention. JACC: Cardiovascular Interventions, 15(8), 797–806. https://doi.org/10.1016/j.jcin.2022.01.300
Authors:
Björn Redfors
Ajay J. Kirtane
Mengdan Liu
Daniel Musikantow
Bernhard Witzenbichler
Michael J. Rinaldi
D. Christopher Metzger
Giora Weisz
Thomas Stuckey
Bruce R. Brodie
Ori Ben‐Yehuda
Roxana Mehran
Gregg W. Stone
Affiliated Authors:
Björn Redfors
Ajay J. Kirtane
Giora Weisz
Ori Ben‐Yehuda
Author Keywords:
discontinuation
drug-eluting stent(s)
dual antiplatelet therapy
percutaneous coronary intervention
platelet reactivity
platelet reactivity
Publication Type:
Article
Unique ID:
10.1016/j.jcin.2022.01.300
PMID:
Publication Date:
Data Source:
OpenAlex

Record Created: